what are glp-1 agonists Video: Non-insulin injectable antidiabetic drugs - and amylinomimetics: Nursing pharmacology GLP-1 receptor agonists show promise
Description
For the treatment of T2D, the FDA gave their approval in 2017
Capacity constraints have already driven significant activity across the GLP-1 value chain
Not peer-reviewed
Henceforth, researchers devised numerous strategies for drug development, mainly by evading the enzymatic degradation of bioactive GLP-1 peptide by DPP-4
ClinicalTrials.gov (2018)
